Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 3475-3483, October 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guess, H.
Right arrow Articles by Peto, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guess, H.
Right arrow Articles by Peto, R.

Uncertainty Estimates for Low-Dose-Rate Extrapolations of Animal Carcinogenicity Data

Harry Guess, Kenny Crump and Richard Peto

National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709 [H. G.]; Louisiana Tech University, Ruston, Louisiana 71270 [K. C.], and University of Oxford, Oxford, England [R. P.]

We explore the statistical uncertainty in low-dose-rate extrapolations of animal carcinogenicity data and state some general conclusions about its magnitude. Our conclusions are based on analyses of both actual data sets from animal experiments and a large number of data sets generated by computer simulation. Our results, which should be applicable to continuous exposure to any "direct-acting" carcinogen, indicate that at low dose rates upper statistical confidence limits on added risk are almost certain to be approximately linear in the dose rate, even when the data trend in the observable range is not linear. When the test data show a definite linear trend, both upper and lower confidence limits on the added risk should be approximately linear and should differ by no more than a factor of about 10 for experiments involving several dozen tumorbearing animals. When the trend does not have a definite linear component, the upper and lower confidence limits on added risk can be expected to differ much more widely; only the upper confidence limits will then be stable and meaningful. The upper confidence limits produced by several different mathematical models are all likely to be much the same, although the lower confidence limits may differ widely. These conclusions should apply as long as the dose-response curve is not forced to have a zero slope at zero dose. In other words, if linearity of the dose-response curve in the low dose range is not ruled out by assumption, it is most unlikely that it can be ruled out empirically on the basis of high-dose-rate animal data.

Received 12/ 6/76. Accepted 6/ 7/77.




This article has been cited by other articles:


Home page
ScienceHome page
B. Ames
Identifying environmental chemicals causing mutations and cancer
Science, May 11, 1979; 204(4393): 587 - 593.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.